Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the heels of a warning from the U.S. Food and Drug Administration (FDA), ...
This week, FDA issued a safety communication connected to Zimmer Biomet’s CPT Hip System Femoral Stem after finding increased risk of thigh bone fracture — postoperative periprosthetic femoral ...
Average physician reimbursement for all hip and knee joint procedures fell more than 30 percent in the past 20 years, according to a study published in The Journal of Arthroplasty. For the study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results